Titan International, Inc.
NYSE:TWIAgricultural - Machinery
+$0.24 today
- Market cap
- $283.62M
- Beta
- 1.47
- P/E (TTM)
- -5.6
- EPS (TTM)
- -$1.36
Volume 0.77M
Average 0.93M
TWI Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Titan International, Inc.NYSE: TWI
Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares (diluted) growth accelerates
Q1 FY2026 weighted avg shares (diluted) of 64.07M shares rose 1.2% year over year, ahead of the -6.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +0.0% a year.
Context
- Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1.2% holds above the trailing-twelve-month pace of -6.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 63.71M USD
- Year-over-year change
- -7.2%
- 4-year CAGR
- +0.4%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 63.71M | -7.2% |
| FY2024 | 2024-12-31 | 68.66M | +9.1% |
| FY2023 | 2023-12-31 | 62.96M | -1.1% |
| FY2022 | 2022-12-31 | 63.69M | +1.6% |
| FY2021 | 2021-12-31 | 62.69M | — |
Weighted Avg Shares (Diluted) vs competitors
How TWI compares with its peers on the latest reported figures
- TWI's LTM Mar 2026 weighted avg shares (diluted) of 63.8M shares is the 5th highest of the 11 companies compared; the peer median is 45.4M shares.
- Its year-over-year change of -6.8% is the lowest of 11, against a peer median of +0.3%.
- Over three fiscal years its annual growth of +0.0% compares with a peer median of +1.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 102.33M | -3.7% | -5.1% | |
| LTM Mar 2026 | 87.58M | +1.3% | +3.7% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | 84.09M | +6.7% | +5.0% |
| LTM Mar 2026 | 75.24M | -0.3% | +2.1% | |
| LTM Mar 2026 | 63.8M | -6.8% | +0.0% | |
| LTM Mar 2026 | 50.01M | +0.9% | +2.9% | |
| LTM Mar 2026 | 40.78M | -2.2% | +2.1% | |
| LTM Mar 2026 | 35.99M | +1.6% | +0.9% | |
| LTM Mar 2026 | 28.79M | -0.4% | -0.1% | |
| LTM Mar 2026 | 27.63M | +6.9% | -1.6% | |
| LTM Mar 2026 | 26.54M | -4.6% | -7.0% | |
| Peer median (excluding TWI) | 45.4M | +0.3% | +1.5% | |
Competitors are the stored peer set for TWI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.78B | 2.17B | 1.82B | 1.85B | 1.83B |
| Cost of Revenue | 1.54B | 1.81B | 1.52B | 1.59B | 1.59B |
| Gross Profit | 237.54M | 360.71M | 305.85M | 257.8M | 242.35M |
| Gross Margin | 13.3% | 16.6% | 16.8% | 14.0% | 13.3% |
| Research & Development | 10.1M | 10.4M | 12.54M | 16.52M | 18.32M |
| Selling, General & Admin | 131.77M | 132.79M | 134.94M | 191.79M | 203.27M |
| Operating Expenses | 152.37M | 154.91M | 157.12M | 224.62M | 221.59M |
| Depreciation & Amortization | 47M | 41.9M | 42.43M | 60.7M | 67.11M |
| EBITDA | 130.26M | 274.05M | 170.97M | 105.4M | 94.52M |
| EBITDA Margin | 7.3% | 12.6% | 9.4% | 5.7% | 5.2% |
| Operating Income | 85.18M | 205.8M | 148.73M | 33.18M | 20.76M |
| Operating Margin | 4.8% | 9.5% | 8.2% | 1.8% | 1.1% |
| Interest Income | 0 | 2.35M | 0 | 11.02M | 10.7M |
| Interest Expense | 32.22M | 32.15M | 18.79M | 36.43M | 38.71M |
| Other Income / Expenses | (34.14M) | (3.45M) | (38.98M) | (24.91M) | (32.06M) |
| Income Before Tax | 51.04M | 202.35M | 109.75M | 8.27M | (11.3M) |
| Pre-Tax Margin | 2.9% | 9.3% | 6.0% | 0.4% | -0.6% |
| Income Tax Expense | 1.15M | 23.17M | 26.04M | 11.86M | 49.89M |
| Net Income | 49.59M | 176.3M | 78.76M | (5.56M) | (63.49M) |
| Net Margin | 2.8% | 8.1% | 4.3% | -0.3% | -3.5% |
| EPS (Basic) | 0.80 | 2.80 | 1.26 | (0.08) | (1.00) |
| EPS (Diluted) | 0.79 | 2.77 | 1.25 | (0.08) | (1.00) |
| Weighted Avg Shares | 62.1M | 63.04M | 62.45M | 68.66M | 63.49M |
| Weighted Avg Shares (Diluted) | 62.69M | 63.69M | 62.96M | 68.66M | 63.71M |
Titan International, Inc.
NYSE:TWI
Intrinsic Alpha fair value
Locked
Current Price
$4.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.